Marksans Pharma Ltd.
MARKSANS Share PricePharmaceuticals & Drugs
₹187.8
-2.4 (-1.3%)
As on December 4, 2025
Exchange Scrips: BSE524404NSEMARKSANSISININE750C01026
Market Cap ₹ 8,497 Cr
P/E Ratio 22.36
Dividend Yield 0.43 %
Performance
Market performance
Open190.2
High190.89
Volumes5,29,293
Prev187.8
Low187
As on2025-12-04
Historical performance
1 Year High358.55
3 Year High358.7
5 Year High358.7
1 Year Low162
3 Year Low57.9
5 Year Low38.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
8,497
Face Value (₹)
1
P/E Ratio
22.36
Dividend Yield
0.43 %
Investment Returns
1 Year
-45.6%
3 Years
221.9%
5 Years
194.1%
10 Years
80.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 190.59 | Bearish |
| 10-DMA | 190.39 | Bearish |
| 20-DMA | 190.76 | Bearish |
| 50-DMA | 181.57 | Bullish |
| 100-DMA | 191.91 | Bearish |
| 200-DMA | 211.97 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 2 | 2 | 2 | 2 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 2 | 2 | 2 | 2 | 2 |
| Public Investors | 265786 | 256219 | 257271 | 259811 | 248843 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 22.36.
- 3Y Stock Price CAGR of the stock is 45.4.
- The stock has a beta of 1.4.
- In the last financial year, the company had an EBITDA of ₹5990 Million.
- The company generated revenue of ₹26228 Million in the previous financial year.
Marksans Pharma Ltd.
187.8-2.4 (-1.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 539035.6
No. of Shares: 2870 (Approx)
Performance:-46.1%
P/L: ₹-460964.4
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
